These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis. Kensler TW, Jayaram HN, Cooney DA. Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804 [Abstract] [Full Text] [Related]
5. Half of Saccharomyces cerevisiae carbamoyl phosphate synthetase produces and channels carbamoyl phosphate to the fused aspartate transcarbamoylase domain. Serre V, Guy H, Penverne B, Lux M, Rotgeri A, Evans D, Hervé G. J Biol Chem; 1999 Aug 20; 274(34):23794-801. PubMed ID: 10446140 [Abstract] [Full Text] [Related]
6. Flux through the de novo pyrimidine pathway in vivo. Effect of N-phosphonacetyl-L-aspartate, a potent inhibitor of aspartate transcarbamylase. Monks A, Anderson LW, Strong J, Cysyk RL. J Biol Chem; 1983 Nov 25; 258(22):13564-9. PubMed ID: 6417130 [Abstract] [Full Text] [Related]
7. Overproduction of the first three enzymes of pyrimidine nucleotide biosynthesis in Drosophila cells resistant to N-phosphonacetyl-L-aspartate. Laval M, Azou Y, Giorgi D, Rosset R. Exp Cell Res; 1986 Apr 25; 163(2):381-95. PubMed ID: 2869965 [Abstract] [Full Text] [Related]
8. Measurement of aspartate carbamoyltransferase activity by high performance liquid chromatography. Grem JL, Drake JC, Allegra CJ. Anticancer Drugs; 1993 Oct 25; 4(5):545-54. PubMed ID: 8292811 [Abstract] [Full Text] [Related]
9. Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA). Friedman J, Moore EC, Hall SW, Loo TL. Cancer Treat Rep; 1979 Jan 25; 63(1):85-8. PubMed ID: 421235 [Abstract] [Full Text] [Related]
10. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate. Zieg J, Clayton CE, Ardeshir F, Giulotto E, Swyryd EA, Stark GR. Mol Cell Biol; 1983 Nov 25; 3(11):2089-98. PubMed ID: 6656764 [Abstract] [Full Text] [Related]
14. Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin). Ardalan B, Jayaram HN, Johnson RK. Cancer Res; 1983 Apr 25; 43(4):1598-601. PubMed ID: 6831405 [Abstract] [Full Text] [Related]
15. Studies on channeling of carbamoyl-phosphate in the multienzyme complex that initiates pyrimidine biosynthesis in rat ascites hepatoma cells. Otsuki T, Mori M, Tatibana M. J Biochem; 1982 Nov 25; 92(5):1431-7. PubMed ID: 6130083 [Abstract] [Full Text] [Related]
16. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines. Peters GJ. Nucleosides Nucleotides Nucleic Acids; 2018 Nov 25; 37(6):329-339. PubMed ID: 29723133 [Abstract] [Full Text] [Related]
17. Induction of CAD gene amplification by restriction endonucleases in V79,B7 Chinese hamster cells. Cavolina P, Agnese C, Maddalena A, Sciandrello G, Di Leonardo A. Mutat Res; 1989 Nov 25; 225(1-2):61-4. PubMed ID: 2563307 [Abstract] [Full Text] [Related]
20. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid. Kensler TW, Mutter G, Hankerson JG, Reck LJ, Harley C, Han N, Ardalan B, Cysyk RL, Johnson RK, Jayaram HN, Cooney DA. Cancer Res; 1981 Mar 25; 41(3):894-904. PubMed ID: 7459875 [Abstract] [Full Text] [Related] Page: [Next] [New Search]